Liver Cirrhosis of the Viral Etiology in Children
https://doi.org/10.22627/2072-8107-2018-17-4-29-33
Abstract
The structure of liver cirrhosis (LC) in children of Uzbekistan was studied. 135 children with viral etiology of liver cirrhosis at the age of 7—15 years of life were examined. It was established that in the structure of viral liver cirrhosis in children, mixed etiology prevails (77.1%) with a predominance of HDV infection (B + C + D — 35.6% and B + D — 23.7%). Mixed infection is considered as a predictor of disease progression, especially in cases of overlap of HDV infection, which was also expressed by the frequent identification of the decompensated stage of the liver cirrhosis C-class of Child-Pugh and complications. Levels of N-terminal propeptides and C-terminal telopeptides of type I collagen in children with liver cirrhosis can serve as markers of compensation and progression of the disease.
About the Authors
F. I. Inoyatova
Republic Specialized Scientific-practical medical Center of Pediatrics of the Ministry of Health of Uzbekistan
Uzbekistan
Uzbekistan
Flora Inoyatova, MD, Professor, Head of Hepatology Department
Tashkent
G Z. Inogamova
Republic Specialized Scientific-practical medical Center of Pediatrics of the Ministry of Health of Uzbekistan
Uzbekistan
Uzbekistan
Gulnoza Inogamova, PhD, Senior Researcher of the Hepatology Department
Tashkent
References
1. Durand F., Valla D. Assessment of the prognosis of cirrhosis: ChildPugh versus MELD. Hepatology. 2005. 42(suppl):100—107.
2. The-La Huo, Shou-Dong Lee, Han-Chieh Lin. Selecting an optimal prognostic system for liver cirrhosis: the model for end-stage liver disease and beyond. Liver Int. 2008. 28(5):606—613.
3. Chuelov S.B., M.O. Gasparyan, G.V. Chaplyginа, O.V. Molochkova, N.A. Guseva, A.L. Rossina, I.B. Bryusova, V.P. Najimov, G.I. Volkova, A.V. Drozdov, L.M. Karpina, A.E. Stepanov, M.N. Sukhov. Differential diagnostic signs and features of the course of liver cirrhosis in viral hepatitis in children. Detskie Infektsii=Children's Infections. 2006; 1: 21—23. (In Russ.)
4. Gottahardt D., Weiss K., Baumgartner M. et al. Limitations of the MELD score in predicting mortality or need for removal from waiting list in patients awaiting liver transplantacion. BMC Gastroenterology. 2009: 167—172.
5. Saab S., Niho H., Comulada S. et al. Mortality predictors in liver transplantant recipients with recurrent hepatitis C cirrhosis. Liver Int. 2005. 25(5):940—945.
6. Tandon P., Garcia-Tsao G. Prognostic indicators in hepatocellular carcinoma: A systematic rewiew of 72 studies. Liver Int. 2009. 29(4):502—510.
7. Inoyatova F.I. Chronic viral hepatitis C in children. Tashkent: Ed. Shark, 2009: 415. (In Russ.)
8. Uchaykin V.F., S.B. Chuelov, A.L. Rossina, A.V. Smirnov, I.B. Bryusovа, G.I. Volkova, A.V. Drozdov, Yu.N. Ivanova, L.M. Karpinа, L.I. Konovalova, V.P. Nazhimov, A.E. Stepanov. Cirrhosis of the liver in children. Pediatriа=Pediatrics. 2008. 87 (5): 52—59. (In Russ.)
9. Fontana R.J., Hann H.W., Perrillo R.P. et al. Determinants of early mortality in patients with decompensated chronic hepatitis B treated with antiviral therapy. Gastroenterology. 2002. 123: 719—727.
10. Forns X., Ampurdanes S., Llovet G.M. et al. Identification of Chronic Hepatitis C Patints Without Hepatic Fibrosis by a Simple Predective Model. Hepatology. 2002. 6(4): 986—992.
11. Moreau R., Deleque P., Pessione F. et al. Clinical characteristics and autcome of patients with cirrhosis and refractor ascites. Liver Int. 2004. 24(5): 267—275.
12. Schiff E., Lai C., Hadziyannis S. et al. Adefovir dipivoxil for wait-listed and post-liver transplantacion patients with lamivudine — resistant hepatitis B: final long-term results. Liver Transpl. 2007. 13: 349—360.
13. Yeung E., Yong E., Wong F. Renal desfunction in cirrohosis: Diagnosis, treatment fnd prevention. Medscape Gen. Med. 2004. 6(4):9.
14. Pirogovа I.Yu., Pyshkin S.A. Algorithm for the differential diagnosis of chronic hepatitis and cirrhosis in patients with chronic HCV-HBV infection. Klinicheskie Perspektivi Gastroenterologii, Hepatologii=Clinical Perspectives Gastroenterol., Hepatology. 2001. 2: 19—26. (In Russ.)
15. Pirogovа I.Yu., Pyshkin S.A. Diagnosis of liver fibrosis: invasive and non-invasive methods. Siberian Medical Journal. 2011. 3: 10—15. (In Russ.)
16. Parkhomenko L.K., Strashok L.A., Buznitskaya E.V. Serum markers in the diagnosis of liver fibrogenesis in adolescents with obesity. Scientific Statements. 2014. 4 (175), Issue 25: 106—110. (In Russ.)
17. Parkhomenko L.K., Strashok L.A., Buznitskaya E.V. Issues of diagnosis of non-alcoholic fatty liver disease in adolescence. Zdorovie Rebenka=Child health. 2011. 7 (34): 107—112. (In Russ.)
Review
For citations:
Inoyatova F.I., Inogamova G.Z. Liver Cirrhosis of the Viral Etiology in Children. CHILDREN INFECTIONS. 2018;17(4):29-33. (In Russ.) https://doi.org/10.22627/2072-8107-2018-17-4-29-33
Views:
866
Email this article 